Exposure-response analyses of sacituzumab govitecan (SG) efficacy and safety in patients (pts) with metastatic triple-negative breast cancer (mTNBC).

被引：0
|
作者：
Singh, Indrajeet
Sathe, Abhishek G.
Singh, Pratap
Diderichsen, Paul M.
Fauchet, Floris
Maringwa, John
Pierrillas, Philippe
Phan, See-Chun
Girish, Sandhya
Othman, Ahmed A.
机构：
[1] Gilead Sci Inc, Foster City, CA USA
[2] Certara USA Inc, Princeton, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1076
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Safety analyses from the phase 3 ASCENT trial of sacituzumab govitecan in metastatic triple-negative breast cancer
    Rugo, Hope S.
    Tolaney, Sara M.
    Loirat, Delphine
    Punie, Kevin
    Bardia, Aditya
    Hurvitz, Sara A.
    O'Shaughnessy, Joyce
    Cortes, Javier
    Dieras, Veronique
    Carey, Lisa A.
    Gianni, Luca
    Piccart, Martine J.
    Loibl, Sibylle
    Goldenberg, David M.
    Hong, Quan
    Olivo, Martin
    Itri, Loretta M.
    Kalinsky, Kevin
    NPJ BREAST CANCER, 2022, 8 (01)
  • [22] ASCENT: A randomized phase III study of sacituzumab govitecan (SG) vs treatment of physician's choice (TPC) in patients (pts) with previously treated metastatic triple-negative breast cancer (mTNBC)
    Bardia, A.
    Tolaney, S. M.
    Loirat, D.
    Punie, K.
    Oliveira, M.
    Rugo, H. S.
    Brufsky, A.
    Kalinsky, K.
    Cortes, J.
    O'Shaughnessy, J.
    Dieras, V. C.
    Carey, L. A.
    Gianni, L.
    Piccart, M.
    Loibl, S.
    Goldenberg, D.
    Hong, Q.
    Olivo, M. S.
    Itri, L. M.
    Hurvitz, S. A.
    ANNALS OF ONCOLOGY, 2020, 31 : S1149 - S1150
  • [23] Assessment of sacituzumab govitecan (SG) versus treatment of physician's choice (TPC) cohort by agent in the phase 3 ASCENT study of patients (pts) with metastatic triple-negative breast cancer (mTNBC).
    O'Shaughnessy, Joyce
    Punie, Kevin
    Oliveira, Mafalda
    Lynce, Filipa
    Tolaney, Sara M.
    Dalenc, Florence
    Sharma, Priyanka
    Tsai, Michaela L.
    Bardia, Aditya
    Cortes, Javier
    Danso, Michael A.
    Henry, Stephanie
    Perez, Alejandra T.
    Hurvitz, Sara A.
    Kalinsky, Kevin
    Hong, Quan
    Sebastian Olivo, Martin
    Itri, Loretta
    Rugo, Hope S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [24] Sacituzumab govitecan (SG) efficacy in patients with metastatic triple-negative breast cancer (mTNBC) by HER2 immunohistochemistry (IHC) status: Findings from the phase III ASCENT study
    Hurvitz, S. A.
    Bardia, A.
    Punie, K.
    Kalinsky, K.
    Cortes, J.
    O'Shaughnessy, J.
    Carey, L. A.
    Rugo, H. S.
    Yoon, O. K.
    Pan, Y.
    Delaney, R. J.
    Hofsess, S.
    Hodgkins, P.
    Phan, S-C.
    Dieras, V.
    ANNALS OF ONCOLOGY, 2022, 33 : S200 - S201
  • [25] Sacituzumab-govitecan in metastatic triple-negative breast cancer: a multicenter effectiveness and safety study
    Carrion-Madronal, Isabel Maria
    Diaz-Acedo, Rocio
    Lora-Escobar, Santiago Jose
    Naranjo-Llamas, Eloisa
    Jaramillo-Ruiz, Didiana
    Artacho-Criado, Silvia
    Prado-Mel, Elena
    FUTURE ONCOLOGY, 2024, 20 (33) : 2565 - 2572
  • [26] Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer
    Bardia, A.
    Mayer, I. A.
    Vahdat, L. T.
    Tolaney, S. M.
    Isakoff, S. J.
    Diamond, J. R.
    O'Shaughnessy, J.
    Moroose, R. L.
    Santin, A. D.
    Abramson, V. G.
    Shah, N. C.
    Rugo, H. S.
    Goldenberg, D. M.
    Sweidan, A. M.
    Iannone, R.
    Washkowitz, S.
    Sharkey, R. M.
    Wegener, W. A.
    Kalinsky, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (08): : 741 - 751
  • [27] Analysis of patients (pts) without an initial triple-negative breast cancer (TNBC) diagnosis (Dx) in the phase III ASCENT study of sacituzumab govitecan (SG) in brain metastases-negative (BMNeg) metastatic TNBC (mTNBC)
    O'Shaughnessy, J.
    Brufsky, A.
    Rugo, H. S.
    Tolaney, S. M.
    Diab, S.
    Punie, K.
    Sardesai, S.
    Hamilton, E.
    Loirat, D.
    Traina, T. A.
    Leon-Ferre, R.
    Hurvitz, S. A.
    Kalinsky, K.
    Bardia, A.
    Henry, S.
    Mayer, I.
    Hong, Q.
    Phan, S.
    Cortes, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S473 - S474
  • [28] Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases
    De Moura, Alexandre
    Loirat, Delphine
    Vaillant, Sarah
    Korbi, Sinen
    Kiavue, Nicolas
    Roufai, Diana Bello
    Escalup, Laurence
    Desmaris, Romain
    Vaflard, Pauline
    Cottu, Paul
    Pierga, Jean-Yves
    Bidard, Francois-Clement
    Cabel, Luc
    Acramel, Alexandre
    BREAST CANCER, 2024, 31 (04) : 572 - 580
  • [29] Sacituzumab Govitecan-hziy in Triple-Negative Breast Cancer
    Ozaki, Yukinori
    Masuda, Jun
    Takano, Toshimi
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (24): : 2382 - 2382
  • [30] Sacituzumab govitecan-hziy for triple-negative breast cancer
    Stirrups, Robert
    LANCET ONCOLOGY, 2019, 20 (04): : E194 - E194
12345